The PE Ratio as of December 2024 (TTM) for SpringWorks Therapeutics, Inc. (SWTX) is -9.61

According to SpringWorks Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -9.61. This represents a change of -16.72% compared to the average of -11.54 of the last 4 quarters.

SpringWorks Therapeutics, Inc. (SWTX) Historical PE Ratio (quarterly & annually)

How has SWTX PE Ratio performed in the past?

The mean historical PE Ratio of SpringWorks Therapeutics, Inc. over the last ten years is -52.83. The current -9.61 PE Ratio has changed 1.72% with respect to the historical average. Over the past ten years (40 quarters), SWTX's PE Ratio was at its highest in in the December 2020 quarter at 76.10. The PE Ratio was at its lowest in in the March 2021 quarter at -29.78.

SpringWorks Therapeutics, Inc. (SWTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of SpringWorks Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SpringWorks Therapeutics, Inc. (SWTX) Average PE Ratio

How has SWTX PE Ratio performed in the past?

The current PE Ratio of SpringWorks Therapeutics, Inc. (SWTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

SpringWorks Therapeutics, Inc. (SWTX) PE Ratio vs. Peers

How is SWTX’s PE Ratio compared to its peers?

SpringWorks Therapeutics, Inc.’s PE Ratio is less than Relay Therapeutics, Inc. (-1.76), less than Stoke Therapeutics, Inc. (-6.20), less than Pliant Therapeutics, Inc. (-4.02), less than Black Diamond Therapeutics, Inc. (-1.69), less than Arvinas, Inc. (-4.21), greater than Day One Biopharmaceuticals, Inc. (-14.55), greater than Mirati Therapeutics, Inc. (-11.26), less than Amylyx Pharmaceuticals, Inc. (-1.07), less than Terns Pharmaceuticals, Inc. (-5.24), greater than Apellis Pharmaceuticals, Inc. (-16.45), less than TCR2 Therapeutics Inc. (-0.38), greater than Revolution Medicines, Inc. (-12.93), less than Atreca, Inc. (-0.06), less than Passage Bio, Inc. (-0.58), greater than Cerevel Therapeutics Holdings, Inc. (-17.73), greater than Avidity Biosciences, Inc. (-13.92), greater than Blueprint Medicines Corporation (-44.71), less than Sana Biotechnology, Inc. (-1.25), greater than Kymera Therapeutics, Inc. (-18.54), less than Monte Rosa Therapeutics, Inc. (-4.90),

Build a custom stock screener for SpringWorks Therapeutics, Inc. (SWTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SpringWorks Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SpringWorks Therapeutics, Inc. (SWTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SpringWorks Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.